|
|
|
Volumn 7, Issue 2, 1996, Pages 315-329
|
|
Clinical aspects of premenstrual syndrome
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
(3 CHLOROPHENYL)PIPERAZINE;
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
ALPRAZOLAM;
ANXIOLYTIC AGENT;
CLOMIPRAMINE;
CLONIDINE;
DANAZOL;
ESTROGEN;
FLUOXETINE;
FLUVOXAMINE;
GONADORELIN AGONIST;
IMIPRAMINE;
LEUPRORELIN;
LITHIUM;
MONOAMINE OXIDASE INHIBITOR;
NALTREXONE;
NEFAZODONE;
NEUROTRANSMITTER;
NORTRIPTYLINE;
OPIATE ANTAGONIST;
ORAL CONTRACEPTIVE AGENT;
PAROXETINE;
PHENELZINE;
PLACEBO;
PROGESTERONE;
PSYCHOTROPIC AGENT;
SEROTONIN AGONIST;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
SEX HORMONE;
UNINDEXED DRUG;
VALPROIC ACID;
ANOREXIA;
BEHAVIOR MODIFICATION;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DISEASE SEVERITY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG MIXTURE;
FATIGUE;
FEMALE;
FOLLICULAR PHASE;
HUMAN;
HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM;
INSOMNIA;
LUTEAL PHASE;
MAJOR CLINICAL STUDY;
MOOD;
OVULATION;
PATHOGENESIS;
PREMENSTRUAL SYNDROME;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SOMNOLENCE;
TREMOR;
VERTIGO;
|
|
EID: 0029863364
PISSN: 10479422
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|
